Your browser doesn't support javascript.
loading
Pre- and postoperative prognostic factors for resectable esophageal adenocarcinoma.
Serralheiro, Pedro; Rankin, Adeline; Clark, Allan; Holyoake, Daniel; Cheong, Edward.
Afiliação
  • Serralheiro P; Faculty of Health Sciences, CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506, Covilhã, Portugal. Electronic address: pserralheiro@fcsaude.ubi.pt.
  • Rankin A; Department of Upper Gastrointestinal Surgery, Norfolk & Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK. Electronic address: ADELINE.RANKIN@nnuh.nhs.uk.
  • Clark A; Norwich Medical School, University of East Anglia, NR4 7TJ, Norwich, UK. Electronic address: ALLAN.CLARK@uea.ac.uk.
  • Holyoake D; Department of Oncology, Norfolk & Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK. Electronic address: DANIEL.HOLYOAKE@nnuh.nhs.uk.
  • Cheong E; Department of Upper Gastrointestinal Surgery, Norfolk & Norwich University Hospital, Colney Lane, Norwich, NR4 7UY, UK. Electronic address: EDWARD.CHEONG@nnuh.nhs.uk.
Surg Oncol ; 35: 132-138, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32871548
ABSTRACT

BACKGROUND:

Prognostication for esophageal cancer has traditionally relied on postoperative tissue specimens. This study aimed to use a histologically homogenous cohort to investigate the relationship between clinical, pathological or radiological variables and overall survival in patients undergoing esophagectomy for adenocarcinoma.

METHODS:

A single-centre study of patients who underwent esophagectomy for adenocarcinoma over 10 years in a tertiary centre was performed. By regression analysis, variables available preoperatively and postoperatively were studied for prognostication. The primary outcome was overall survival.

RESULTS:

254 cases were analyzed. Over a median follow-up period of 31.8 months (IQR = 42.5), overall survival was 51.5 months (95% confidence interval 33.0-69.9). According to hazard ratios (HR) for all-cause death, adverse prognostic factors included a higher postoperative N-stage (HR ≥ 1.29; p ≤ 0.024), histopathological tumor length ≥25 mm (HR = 2.04; p = 0.03), poorer tumor differentiation (HR ≥ 2.86; p ≤ 0.042), and R1 status (HR = 2.33; p = 0.02). A lymph node yield ≥35 was a favorable prognostic factor (HR = 0.022; p < 0.001). Demographic and radiological variables, preoperative TNM stages, postoperative T-stage, and neoadjuvant/adjuvant treatment were not associated with overall survival.

CONCLUSIONS:

This study identifies several postoperatively factors which are available for the prognostication and identifies factors that should not be used to exclude patients from curative surgery.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Pós-Operatórios / Cuidados Pré-Operatórios / Neoplasias Esofágicas / Adenocarcinoma / Esofagectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cuidados Pós-Operatórios / Cuidados Pré-Operatórios / Neoplasias Esofágicas / Adenocarcinoma / Esofagectomia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article